Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-020943
Filing Date
2017-04-18
Accepted
2017-04-18 18:00:42
Documents
2
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 v464417_3.html 3  
1 FORM 3 v464417_3.xml 3 1638
2 EXHIBIT 24 v464417_ex24.htm EX-24 3663
  Complete submission text file 0001144204-17-020943.txt   6709
Mailing Address
Business Address
DRISCOLL FREDERICK W (Reporting) CIK: 0001129890 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 17767792

Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations